RELB anticorps (AA 550-554)

N° du produit ABIN5689617

Cet anticorps Lapin Polyclonal détecte spécifiquement RELB dans WB. Il présente une réactivité envers Humain et Souris.

Aperçu rapide pour RELB anticorps (AA 550-554) (ABIN5689617)

Antigène: RELB (V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RELB est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-RELB anticorps

Épitope: AA 550-554

Specificité: This antibody detects endogenous level of total RelB protein.

Purification: Antibodies were purified by affinity-chromatography using epitope-specific peptide.

Immunogène: RelB (Ab-573) antibody was raised against a peptide sequence around aa. 550~554 (L-L-S-P-G) derived from Human RelB.

Information d'application

Indications d'application: Western Blot: 1:500~1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+),  pH 7.4, 150  mM NaCl, 0.02 % sodium azide and 50 % glycerol.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store antibody at -20°C for up to one year.

Détails sur RELB

Antigène: RELB (V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))

Autre désignation: RelB

Sujet: NF-κ,-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-κ,-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-κ,-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-κ,-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-κ,-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-κ,-B complex which translocates to the nucleus. NF-κ,-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49.

Poids moléculaire: 70 kDa

ID gène: 5971

NCBI Accession: NP_006500

UniProt: Q01201

Pathways: Signalisation NF-kappaB, Signalisation RTK